Fumarate Hydratase-Deficient Renal Cell Carcinoma

Introduction: Fumarate hydratase FH deficiency is very rare disorder. characterized by educed FH enzyme activity .Fumarate hydratase-deficient renal cell carcinoma RCC is a rare pathological subtype. Case Description: We reported a 33 years old male know to have diabetes and hypertension well controlled .presented with complains of right side loin pain. and visible haematuria . no family history or renal disease.renal function normal. Urine showed RBC. Clinical examination unremarkable. CT showed large infiltrating tumour in the right kidney. biopsy of renal mass showed renal RCC .However, as the patient is young. translocation related tumours considered hence immunohistochemistry performed it showed diagnosis of a fumarate hydratase-deficient RCC. plan was to start the patient on immunotherapy in the form bevacizumab and erlotinib and to repeat the CT if CT improved then to do nephrectomy. Discussion: Fumarate catalysed to malet by fumarate FH enzyme in Krebs cycles.deficiency of FH enzyme due to Genetic disorder lead to accumulation fumarate intracellularly and extracellularly. Its rare disorder. mode of transmission is autosomal recessive.accumulation of fumarate may function as an oncometabolite .in homozygous FH deficiency causes sever neonatal neurological defect ,dysmorphic feature and brain abnormalities.prognosis is poor most of severely affected child do not survive .The heterozygotes form majority of cases are healthy.however,they may develop tumours like cutaneous leiomyomata uterine fibroids and uterine myomas also may develop RCC known as Hereditary Leiomyomatosis with Renal Cell carcinoma HLRCC .In regards to RCC associated with FH deficiency defined as a rare pathological subtype (WHO 5th edition 2022) .due to mutations in the FH gene. Diagnosed based on a molecular and immunohistochemical biomarkers.The incidence is very rare and only a few hundreds of cases reported.average age onset between 20 -25. Unfortunately its highly metastasize and very invasive. main treatment is nephrectomy. immunotherapy considered new hope in these patients treatment.Family member of high risk needs early genetic counselling and testing also renal surveillance.Conclusion ,FH deficiency is an autosomal recessive disease .due to accumulation of fumarate. It may associated with RCC FH deficient. Its rare disease very invasive .in young age with RCC advised to investigate for FH deficiency as possible cause.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.20245tzxte44
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fumarate Hydratase-Deficient Renal Cell Carcinoma

Emad S. Khater
Journal of the American Society of Nephrology
Renal cell carcinoma treatment
article

Fumarate Hydratase-Deficient Renal Cell Carcinoma

Emad S. Khater
article en

Abstract

Introduction: Fumarate hydratase FH deficiency is very rare disorder. characterized by educed FH enzyme activity .Fumarate hydratase-deficient renal cell carcinoma RCC is a rare pathological subtype. Case Description: We reported a 33 years old male know to have diabetes and hypertension well controlled .presented with complains of right side loin pain. and visible haematuria . no family history or renal disease.renal function normal. Urine showed RBC. Clinical examination unremarkable. CT showed large infiltrating tumour in the right kidney. biopsy of renal mass showed renal RCC .However, as the patient is young. translocation related tumours considered hence immunohistochemistry performed it showed diagnosis of a fumarate hydratase-deficient RCC. plan was to start the patient on immunotherapy in the form bevacizumab and erlotinib and to repeat the CT if CT improved then to do nephrectomy. Discussion: Fumarate catalysed to malet by fumarate FH enzyme in Krebs cycles.deficiency of FH enzyme due to Genetic disorder lead to accumulation fumarate intracellularly and extracellularly. Its rare disorder. mode of transmission is autosomal recessive.accumulation of fumarate may function as an oncometabolite .in homozygous FH deficiency causes sever neonatal neurological defect ,dysmorphic feature and brain abnormalities.prognosis is poor most of severely affected child do not survive .The heterozygotes form majority of cases are healthy.however,they may develop tumours like cutaneous leiomyomata uterine fibroids and uterine myomas also may develop RCC known as Hereditary Leiomyomatosis with Renal Cell carcinoma HLRCC .In regards to RCC associated with FH deficiency defined as a rare pathological subtype (WHO 5th edition 2022) .due to mutations in the FH gene. Diagnosed based on a molecular and immunohistochemical biomarkers.The incidence is very rare and only a few hundreds of cases reported.average age onset between 20 -25. Unfortunately its highly metastasize and very invasive. main treatment is nephrectomy. immunotherapy considered new hope in these patients treatment.Family member of high risk needs early genetic counselling and testing also renal surveillance.Conclusion ,FH deficiency is an autosomal recessive disease .due to accumulation of fumarate. It may associated with RCC FH deficient. Its rare disease very invasive .in young age with RCC advised to investigate for FH deficiency as possible cause.

Journal of the American Society of NephrologyVol. 35(10S)
Abu Dhabi Health Services (AE)
Openalex Percentile: Top 65%
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.